Par Drugs And Chemicals Limited (PAR) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE04LG01015
Key metrics
- Market Cap
- ₹163 Cr
- P/E Ratio
- 12.43
- EPS
- 10.65
- Book Value
- 91.01
- P/B Ratio
- 1.45
- ROE
- 11.71%
- ROCE
- 11.99%
- Debt / Equity
- —
- Net Margin
- 12.65%
- Revenue Growth
- 2.66%
- Profit Growth
- -1.87%
- Dividend Yield
- —
- 52W High
- ₹132.66
- 52W Low
- ₹78.05
- Market Cap Band
- micro cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, Alusil, PARSIL-HT, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
- Headquarters
- Vadodara, India
The full Par Drugs And Chemicals Limited analysis
Create a free account to open the complete PAR deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.